Dian Kortleve

Company: Pan Cancer T

Job title: Scientist

Seminars:

Identification & Testing of Novel Cancer-Restricted Targets & Their TCRS to Develop Safe & Effective T-Cell Treatment 5:30 pm

To fully exploit the therapeutic potential of TCR-T cells, we use our platform to: Limit toxicity attributed to recognition of identical or highly similar targets outside cancers Deliver shared intracellular targets that are cancer-selective to treat large cohorts of patients Counteract the immune-suppressive nature of tumour microenvironmentsRead more

day: Day 1 – Track A – Evening